The origin of these neoplastic giant cells, called Reed-Sternberg cells, and how they have attracted their accompanying benign lymphocytes, have baffled scientists and hematologists for many decades. These malignant cells are now considered to be derived from B lymphocytes, and yet they do not express many molecules that are found in most B lymphocytes, and doubts remain about the true origin of these malignant cells.
In a paper published in the Proceedings of the National Academy of Sciences (PNAS) earlier this month, the laboratory of Dr. Lloyd J. Old of the Ludwig Institute for Cancer Research (LICR), together with Dr. Yao-Tseng Chen at Weill Cornell Medical College and their collaborators, made the finding that CT45, a cancer/testis (CT) antigen normally expressed in testicular germ cells in both prenatal and adult life, is expressed by the Reed-Sternberg cells in most of the classical Hodgkin lymphomas.
CT antigen was a term coined by Old and Chen in 1996 to describe an unusual group of germ cell antigens that they and others had discovered in their quest for tumor antigens for cancer immunotherapy. This group of antigens is normally silenced in all other normal cells in adult, and yet is aberrantly activated and expressed in a subset of various human cancers, often eliciting immune response in cancer patients.
Chen and Old discovered CT45 in 2005 and went on to show that CT45 is expressed in many cancers, notably in ovarian cancer and lung cancer. In contrast to the expression of CT45 in these epithelial cancers, they described in the current paper that CT45 expression in Hodgkin lymphoma is much more frequent, particularly when compared to other CT antigens, which are expressed in 0-25% in Hodgkin lymphoma. This high frequency of strong expression of CT45 in Hodgkin lymphoma indicates that CT45 could be a cancer vaccine target for Hodgkin lymphoma and related grey-zone lymphoma—lymphomas that bear the characteristics of both classic Hodgkin lymphoma as well as diffuse large B cell lymphoma, or non-Hodgkin lymphoma.
Even more intriguing, this finding points to a link between the malignant transformation in Hodgkin lymphoma and the process of germ cell development. These findings strengthen the theory that CT-coding genes that are active at the earliest stages of life, silenced in normal adult tissue, and then re-expressed in cancer, are major contributors to the abnormal growth and invasive properties of cancer.Contact:
About the Ludwig Institute for Cancer Research (LICR) New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center (MSKCC). The New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center is one of the ten research branches of the Ludwig Institute for Cancer Research, a global non-profit institute committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery.
The New York Branch of Human Cancer Immunology’s main objective is the identification of suitable targets for antibody-based and vaccine-based immunotherapies of cancer. Over the years, the laboratory has defined a wide range of antibodies that target cell surface antigens on human cancer cells, as well as a range of intracellular antigens targeted by humoral and cellular immune responses. Based on detailed serological, biochemical, cellular, immunohistochemical and genetic characterization, a number of these antibodies and tumor antigens have been selected for early phase clinical trials. http://www.licr.org
Further reports about: > B lymphocytes > B-cell lymphoma > B-cell lymphomas > CT-coding genes > CT45 > Cancer > Hodgkin lymphoma > Human vaccine > Immunology > LICR > Memorial > Reed-Sternberg cells > Reproductive Cells > Sloan-Kettering > grey-zone lymphoma > immune response > malignant cells > methanol fuel cells
Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover
First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences